Aflac (AFL)

Company ID: 73 | CIK: 0000004977
10-Q view:
No 10-Q YTD data
No 10-Q 3M data
No 10-Q YTD data
No 10-Q 3M data
No 10-Q YTD data
No 10-Q 3M data
No 10-Q YTD data
No 10-Q 3M data
No 10-K data
No 10-Q YTD data
No 10-Q 3M data
No 10-K data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q YTD data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-K data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
Segments are charted by their disclosed metrics (revenue, segment profit, etc.). Each line is a single segment. Reconciliation/corporate items are excluded. Major customers are shown as a percentage of revenue. Operational KPIs are grouped by metric concept; sub-metrics appear as separate lines.

Geographic Segments

No 10-Q data
No 10-Q data

Business Unit / Product Segments

No 10-Q data
No 10-Q data

Major Customers (% of Revenue)

No major-customer concentration data found.

Operational KPIs

Dai-ichi Life representatives (advisors)

Investments and cash (aum)

No 10-Q data

New annualized premium sales (bookings)

No 10-Q data

Banks with agreements (branches)

Solvency margin ratio (combined_ratio)

No 10-Q data

Average weekly producers (contractors)

Approximate shareholders (customers)

Employees with disabilities (headcount)

Yen-denominated borrowings (loans_outstanding)

No 10-K data

Benefit ratio (loss_ratio)

Profit repatriations (net_flows)

Return on average invested assets (net_interest_margin)

No 10-K data

Nonaccrual loans (nonperforming_loans)

No 10-Q data

10-year Japanese government bond yield (other)

No 10-K data

A rated securities (other)

No 10-K data

AA rated securities (other)

No 10-K data

AAA rated securities (other)

No 10-K data

Active Agents (other)

No 10-Q data

Active agents (other)

No 10-Q data

Active producing agents (other)

No 10-Q data

Active producing agents U.S. (other)

No 10-Q data

Active sales agents (other)

No 10-Q data

Actively producing U.S. associates (other)

No 10-K data

Actively producing agents (other)

No 10-K data

Actively producing sales associates (other)

No 10-Q data

Adjusted EPS diluted (other)

No 10-K data

Adjusted book value (other)

Adjusted book value excluding FX remeasurement (other)

No 10-Q data

Adjusted book value per common share (other)

No 10-K data

Adjusted book value per common share excluding FX remeasurement (other)

No 10-K data

Adjusted book value per share (other)

No 10-K data

Adjusted earnings (other)

Adjusted earnings per diluted share (other)

No 10-K data

Adjusted expense ratio (other)

No 10-K data

Adjusted return on average invested assets (other)

No 10-K data

Adjusted return on equity (other)

No 10-Q data

Adjusted return on equity excluding FX remeasurement (other)

No 10-Q data

Advertising expense (other)

No 10-K data

Aflac Japan share of adjusted revenues (other)

No 10-Q data

Aflac Japan share of total assets (other)

No 10-Q data

Agencies (other)

No 10-Q data

Agencies in Japan (other)

No 10-Q data

Agencies recruited (other)

Agencies recruited in Japan (other)

No 10-Q data

Alliance policies sold (other)

No 10-K data

Amortized hedge costs (other)

No 10-K data

Amortized hedge income (other)

No 10-K data

Annualized Premiums in Force (other)

No 10-Q data

Annualized amortized hedge costs (other)

No 10-K data

Annualized premiums in force (other)

Annualized premiums in force (yen) (other)

No 10-Q data

Annualized premiums in force growth (other)

No 10-K data

Approximate Shareholders (other)

No 10-Q data

Asset duration (other)

No 10-Q data

Asset/liability duration (other)

No 10-Q data

Average U.S. agents producing (other)

No 10-Q data

Average Yen/Dollar exchange rate (other)

No 10-K data

Average exchange rate (other)

No 10-K data

Average producing agents (other)

No 10-Q data

Average producing sales associates (other)

No 10-Q data

Average weekly producers (other)

No 10-Q data

Average yen/dollar exchange rate (other)

No 10-K data

Average yen/dollar rate (other)

No 10-K data

Average yield on available cash flow (other)

No 10-K data

Average yield on new money (other)

No 10-K data

BBB rated securities (other)

No 10-K data

Bancassurance bank partners (other)

No 10-K data

Bank agreements (other)

No 10-Q data

Bank channel agreements (other)

Bank channel new sales (other)

No 10-Q data

Bank channel share of new sales (other)

No 10-Q data

Bank distribution agreements (other)

Bank distribution outlets (other)

Bank distribution partners (other)

No 10-Q data

Bank outlets (other)

No 10-K data

Bank partners (other)

No 10-Q data

Bank partnerships (other)

No 10-Q data

Bank sales agreements (other)

No 10-K data

Bank selling agreements (other)

Banks selling Aflac products (other)

Banks selling products (other)

Banks with agreements (other)

Banks with distribution agreements (other)

No 10-K data

Banks with product agreements (other)

No 10-K data

Banks with sales agreements (other)

Banks with selling agreements (other)

No 10-K data

Below-investment-grade holdings (other)

No 10-K data

Below-investment-grade securities (other)

No 10-K data

Benefit administration platforms (other)

No 10-Q data

Book value per common share (other)

No 10-K data

Book value per share (other)

No 10-K data

Cancer life policies sold (other)

No 10-Q data

Cancer life policies sold via Dai-ichi Life (other)

No 10-Q data

Cancer policies sold (other)

No 10-Q data

Cancer policies sold by Dai-ichi Life (other)

No 10-Q data

Cancer policies sold via Dai-ichi (other)

No 10-Q data

Cancer policies sold via Dai-ichi alliance (other)

No 10-Q data

Cancer policies sold via alliance (other)

No 10-Q data

Care insurance market share (other)

No 10-Q data

Cash and cash equivalents (other)

No 10-K data

Cash and short-term investments (other)

No 10-K data

Cash collateral held (other)

No 10-K data

Cash dividends per share (other)

Cash flow invested (other)

No 10-K data

Cash returned to shareholders (other)

No 10-Q data

Collar program notional (other)

No 10-K data

Collateral for loaned securities (other)

No 10-K data

Collateral held (other)

No 10-K data

Collected premiums by state (other)

No 10-Q data

Combined RBC ratio (other)

No 10-Q data

Common Shares Outstanding (other)

No 10-Q data

Common Stock Outstanding (other)

No 10-Q data

Common shareholders (other)

No 10-Q data

Common shares outstanding (other)

Common stock outstanding (other)

No 10-Q data

Common stock shares outstanding (other)

No 10-Q data

Credit quality distribution (other)

No 10-K data

Credit quality mix (other)

No 10-Q data

Credit rating mix (other)

No 10-K data

Cumulative shares repurchased (other)

No 10-K data

Cumulative treasury shares purchased (other)

No 10-K data

Cyber incident affected individuals (other)

No 10-Q data

DAC to premium ratio (other)

No 10-K data

Dai-ichi Life policy sales (other)

No 10-Q data

Dai-ichi Life representatives (other)

No 10-Q data

Debt securities credit quality (other)

No 10-K data

Debt securities credit rating (other)

No 10-K data

Debt securities credit rating distribution (other)

No 10-K data

Debt securities duration (other)

No 10-Q data

Debt securities portfolio yield (other)

No 10-K data

Debt securities rated A (other)

No 10-K data

Debt securities rated AA (other)

No 10-K data

Debt securities rated AAA (other)

No 10-K data

Debt securities rated BB (other)

No 10-K data

Debt securities rated BBB (other)

No 10-K data

Debt to capitalization (other)

Debt to capitalization ratio (other)

No 10-K data

Debt to total capitalization (other)

Debt to total capitalization ratio (other)

No 10-K data

Deferred Policy Acquisition Costs (other)

No 10-Q data

Deferred acquisition cost ratio (other)

No 10-Q data

Dividend per share (other)

No 10-K data

Dividends per share (other)

No 10-Q data

Earthquake claims provision (other)

No 10-K data

Economic Solvency Ratio (other)

No 10-Q data

Economic solvency ratio (other)

No 10-Q data

Effective income tax rate (other)

Effective tax rate (other)

Effective tax rate on operating earnings (other)

No 10-K data

Electronic policy processing (other)

No 10-Q data

End-of-period yen/dollar exchange rate (other)

No 10-K data

Equity portfolio beta (other)

No 10-K data

Equity securities portfolio beta (other)

No 10-K data

Estimated deferred tax liability (other)

No 10-K data

Estimated remaining Y2000 costs (other)

No 10-K data

Estimated remaining Year 2000 costs (other)

No 10-K data

Exchange rate (other)

No 10-K data

Expected profit repatriation (other)

No 10-K data

Expense ratio (other)

FX forward notional (other)

No 10-K data

FX forward notional outstanding (other)

No 10-K data

FX option notional (other)

No 10-K data

Favorable claims development (other)

No 10-K data

Financial institutions exposure (other)

No 10-K data

Financial strength rating (other)

No 10-K data

Fixed maturities by credit rating (other)

No 10-K data

Fixed maturity portfolio yield (other)

No 10-K data

Fixed swap rate (other)

No 10-K data

Fixed-maturity credit quality (other)

No 10-K data

Fixed-maturity credit rating mix (other)

No 10-K data

Fixed-maturity portfolio yield (other)

Fixed-maturity portfolio yield to maturity (other)

No 10-K data

Fixed-maturity securities by rating (other)

No 10-K data

Fixed-maturity yield to maturity (other)

No 10-K data

Floating interest rate (other)

No 10-K data

Foreign currency forwards notional (other)

No 10-K data

Foreign currency options notional (other)

No 10-K data

Foreign exchange forward contracts (other)

No 10-K data

Funds received from AFLAC Japan (other)

No 10-K data

Funds repatriated from Japan (other)

No 10-Q data

Future policy benefits liability (other)

No 10-Q data

Group insurance sales (other)

No 10-K data

Group products new sales (other)

No 10-Q data

Hypothetical reduction in fair value (other)

No 10-K data

Individuals affected by cyber incident (other)

No 10-Q data

Insurance agencies (other)

No 10-Q data

Insurance agencies in Japan (other)

No 10-Q data

Interest rate sensitivity (other)

No 10-K data

Interest rate sensitivity of debt securities (other)

No 10-K data

Interest rate swaps (other)

No 10-K data

Invested assets (other)

No 10-K data

Investment portfolio yield (other)

Investment yield (other)

Investment-grade securities (other)

No 10-K data

Japan Post cancer share (other)

No 10-Q data

Japan Post offices (other)

No 10-K data

Japan Post outlets (other)

No 10-Q data

Japan Post outlets selling cancer products (other)

No 10-Q data

Japan Post postal outlets (other)

No 10-Q data

Japan fixed-maturity yield (other)

No 10-K data

Japan new sales channel mix (other)

No 10-Q data

Japan new sales channel share (other)

No 10-Q data

Japan portfolio book yield (other)

No 10-K data

Japan portfolio yield (other)

No 10-K data

Japan return on invested assets (other)

No 10-K data

Japan sales agencies (other)

No 10-K data

Japan sales mix (other)

No 10-Q data

Japan share of total assets (other)

No 10-Q data

Japan share of total revenues (other)

No 10-Q data

Japan statutory net assets (other)

No 10-Q data

Japanese government bond yield (other)

No 10-K data

Liability duration (other)

No 10-Q data

Licensed Agents (other)

No 10-Q data

Licensed agents (other)

No 10-Q data

Licensed agents in Japan (other)

No 10-Q data

Licensed insurance agents (other)

No 10-Q data

Licensed sales agents (other)

No 10-Q data

Licensed sales associates (other)

Licensed sales associates and brokers (other)

No 10-K data

Life insurance in force (other)

No 10-Q data

Living benefit product mix (other)

No 10-K data

Living benefit rider share of new sales (other)

No 10-K data

Living benefit riders sold (other)

No 10-Q data

Market directors and broker sales professionals (other)

No 10-Q data

Market value of voting stock (other)

No 10-Q data

Net earnings (other)

No 10-Q data

Net earnings per diluted share (other)

No 10-K data

Net investment hedge (other)

No 10-K data

Net investment hedge designated (other)

No 10-K data

Net investment income (other)

No 10-Q data

Net investment yield (other)

No 10-Q data

Net unrealized gains on debt securities (other)

No 10-K data

Net unrealized gains on securities (other)

No 10-K data

New agencies recruited (other)

New agents recruited (other)

No 10-K data

New annualized premium sales (other)

New annualized premium sales (yen) (other)

No 10-Q data

New annualized premium sales growth (other)

No 10-K data

New annualized premium sales mix (other)

No 10-K data

New average weekly producers growth (other)

No 10-Q data

New business via laptop (other)

No 10-Q data

New cash flow yield (other)

No 10-K data

New money investment yield (other)

New money rate (other)

No 10-Q data

New money yield (other)

New money yield (blended) (other)

No 10-K data

New money yield (yen) (other)

No 10-K data

New money yield to maturity (other)

No 10-K data

New payroll accounts growth (other)

No 10-Q data

New purchase yield to maturity (other)

No 10-K data

New sales (other)

No 10-Q data

New sales agencies recruited (other)

No 10-Q data

New sales associates recruited (other)

New sales channel mix (other)

No 10-Q data

New sales distribution mix (other)

No 10-Q data

New sales growth (other)

No 10-K data

New sales mix (other)

No 10-Q data

New sales product mix (other)

New weekly producers growth (other)

No 10-Q data

Number of Reportable Segments (other)

Offices in Japan (other)

No 10-Q data

Operating EPS growth (other)

No 10-K data

Operating EPS growth ex-currency (other)

No 10-K data

Operating EPS growth excluding currency (other)

No 10-K data

Operating cash flow (other)

No 10-Q data

Operating earnings per diluted share (other)

Operating earnings per share (other)

Operating earnings per share growth (other)

No 10-Q data

Operating expense ratio (other)

Operating return on equity (other)

No 10-Q data

Overall investment yield (other)

No 10-Q data

Payroll business processed electronically (other)

No 10-Q data

Payroll life share of new sales (other)

No 10-K data

Period-end yen/dollar rate (other)

No 10-K data

Policy liabilities growth (other)

No 10-K data

Policy liability duration (other)

No 10-Q data

Portfolio book yield (other)

Portfolio investment yield (other)

Portfolio yield (other)

Portfolio yield to maturity (other)

No 10-K data

Post office distribution points (other)

No 10-Q data

Post office outlets (other)

No 10-K data

Post offices (other)

No 10-Q data

Post offices offering Aflac cancer products (other)

No 10-Q data

Post offices offering Aflac products (other)

No 10-K data

Post offices offering products (other)

Post offices selling products (other)

Postal outlets (other)

No 10-Q data

Postal outlets offering cancer products (other)

No 10-K data

Postal outlets selling Aflac (other)

No 10-Q data

Postal outlets selling cancer insurance (other)

No 10-K data

Premium income growth (other)

No 10-K data

Premiums in force growth (other)

No 10-K data

Premiums lapsed and surrendered (other)

No 10-Q data

Pretax adjusted profit margin (other)

Pretax operating earnings margin (other)

No 10-K data

Pretax operating margin (other)

Pretax operating profit margin (other)

Private placement investments (other)

No 10-K data

Private placement share (other)

No 10-K data

Private placement share of fixed maturities (other)

No 10-K data

Privately issued securities (other)

No 10-K data

Producing agents (other)

Producing sales agents (other)

No 10-Q data

Producing sales associates (other)

No 10-Q data

Profit remittance from Aflac Japan (other)

No 10-K data

Profit repatriated (other)

No 10-K data

Profit repatriation (other)

No 10-K data

Profit repatriation from Japan (other)

No 10-Q data

Profit repatriation to AFLAC U.S. (other)

No 10-K data

Public float value (other)

No 10-Q data

RBC ratio (other)

RBC ratio range (other)

No 10-K data

Recruited agencies (other)

No 10-K data

Registered Shareholders (other)

No 10-Q data

Registered common shareholders (other)

No 10-Q data

Registered shareholders (other)

No 10-Q data

Remaining repurchase authorization (other)

No 10-K data

Remote workforce share (other)

Repurchase authorization (other)

No 10-K data

Repurchase authorization remaining (other)

No 10-K data

Return on average invested assets (other)

Return on average investments (other)

No 10-Q data

Return on average shareholders' equity (other)

No 10-Q data

Return on avg invested assets (other)

No 10-Q data

Return on invested assets (other)

Revised EVER policies sold (other)

No 10-Q data

Rider MAX share of sales (other)

No 10-K data

Riders sold (other)

No 10-Q data

Risk-Based Capital Ratio (other)

No 10-Q data

Risk-Based Capital ratio (other)

No 10-Q data

Risk-based Capital Ratio (other)

No 10-Q data

Risk-based capital ratio (other)

Sales agencies (other)

Sales associates (other)

No 10-Q data

Sales offices (other)

No 10-Q data

Securities lending collateral (other)

No 10-K data

Securities loaned outstanding (other)

No 10-K data

Securities on loan (other)

No 10-K data

Security lending investment income (other)

No 10-K data

Security loans outstanding (other)

No 10-K data

Service offices (other)

No 10-Q data

Share repurchase authorization remaining (other)

Share repurchase program (other)

No 10-K data

Share repurchases (other)

No 10-K data

Shareholders' equity (other)

Shares authorized for repurchase (other)

No 10-K data

Shares available for purchase (other)

No 10-K data

Shares available for repurchase (other)

No 10-K data

Shares issued (other)

No 10-K data

Shares outstanding (other)

Shares remaining for purchase (other)

No 10-K data

Shares remaining for repurchase (other)

No 10-K data

Shares remaining under repurchase authorization (other)

No 10-K data

Shares repurchased (other)

Shares repurchased YTD (other)

No 10-K data

Shares repurchased cumulative (other)

No 10-K data

SmartApp processing share (other)

No 10-Q data

Solvency Margin Ratio (other)

No 10-Q data

Solvency margin ratio (other)

Split-rated holdings (other)

No 10-K data

Split-rated securities (other)

No 10-K data

Spot yen/dollar exchange rate (other)

No 10-K data

Spot yen/dollar rate (other)

No 10-K data

Statutory capital and surplus (other)

Stock options outstanding (other)

No 10-K data

TSE-listed companies reached (other)

No 10-Q data

Television stations (other)

No 10-Q data

Third sector sales growth (other)

No 10-K data

Total adjusted capital (other)

No 10-Q data

Total assets (other)

Total fixed maturity securities (other)

No 10-Q data

Total investments and cash (other)

No 10-Q data

Total operating expense ratio (other)

No 10-Q data

Total premiums written (other)

No 10-Q data

Total shares repurchased (other)

No 10-K data

Treasury shares (other)

No 10-K data

Treasury shares available (other)

No 10-K data

Treasury shares held (other)

No 10-K data

Treasury shares purchased (other)

No 10-K data

Treasury shares purchased since inception (other)

No 10-K data

Treasury shares repurchased (other)

No 10-K data

Treasury stock purchases (other)

No 10-K data

Treasury stock repurchase authorization remaining (other)

No 10-Q data

Treasury stock shares (other)

No 10-K data

Treasury stock shares available (other)

No 10-K data

U.S. portfolio book yield (other)

No 10-K data

U.S. portfolio yield (other)

No 10-K data

U.S. return on invested assets (other)

No 10-K data

U.S. sales associates and brokers (other)

No 10-Q data

U.S. sales mix (other)

No 10-Q data

Unhedged USD portfolio (other)

No 10-K data

Unpaid policy claims (other)

No 10-K data

WAYS product new sales (other)

No 10-Q data

Weekly producing agents (other)

No 10-Q data

Weekly producing associates (other)

No 10-Q data

Weighted average remaining tenor (other)

No 10-K data

Weighted average yen/dollar rate (other)

No 10-K data

Weighted-average maturity (other)

No 10-Q data

Weighted-average yen/dollar exchange rate (other)

No 10-K data

Weighted-average yen/dollar rate (other)

No 10-K data

Year 2000 costs capitalized (other)

No 10-K data

Year 2000 costs incurred (other)

No 10-K data

Year 2000 remaining cost estimate (other)

No 10-K data

Yen profit repatriated (other)

No 10-K data

Yen-denominated borrowings hedged (other)

No 10-K data

Yen-denominated net asset position (other)

No 10-K data

Yen-denominated net assets (other)

No 10-K data

Yen-denominated net assets subject to currency fluctuation (other)

Yen-denominated share of net earnings (other)

No 10-K data

Yen/Dollar exchange rate (other)

No 10-K data

Yen/dollar exchange rate (other)

Yen/dollar spot exchange rate (other)

No 10-K data

Yen/dollar spot rate (other)

No 10-K data

Yield on debt securities portfolio (other)

No 10-K data

Yield on fixed-maturity portfolio (other)

No 10-K data

Yield on new money (other)

No 10-K data

Yield to maturity (other)

No 10-K data

Yield-to-maturity on new investments (other)

No 10-K data

Premium persistency (persistency)

Annualized premiums in force (policies_in_force)

New annualized premium sales (premiums_written)

Television stations (properties)

No 10-Q data

Common shares outstanding (shares)

No 10-Q data

Office square footage (square_footage)

No 10-Q data

Aflac Service Shops (stores)

Risk-based capital ratio (tier1_capital)

Rider MAX riders sold (units_shipped)

No 10-Q data

Jet-issued policy rate (utilization_rate)

No 10-Q data
Human capital disclosures. Workforce totals and demographics are point-in-time. Flow metrics use the year-to-date period for 10-Q and full year for 10-K. Workforce actions (RIFs, restructurings, acquisition-related changes) are listed in the table at the bottom.

Workforce Totals

No 10-Q data
No 10-Q data
No 10-Q data

Demographics

No 10-Q data
No 10-Q data
No 10-Q data
No 10-Q data
No 10-Q data
No 10-Q data
No 10-Q data
No 10-Q data
No 10-Q data
No 10-Q data

Workforce Breakdowns

No 10-K data
No 10-Q data
No 10-Q data
No 10-Q data

HCM Metrics — Point-in-Time

No point-in-time HCM metrics found.

HCM Metrics — Flow (Annual / YTD)

Workforce Actions

Period EndTypeStatusAffected% WorkforceAnnouncedExpected CompletionGeographySegment / FunctionChargeSourceNote
2022-12-31voluntary_separationcompleted2020-09-012021-03-31United StatesCorporateUSD 43 (millions)Note 14. Benefit Plans
f5-10k / Qwen3.6-27B-Q8_0
Program announced in Sept 2020; most transitions completed by Dec 31, 2020, with a small number continuing into Q1 2021. Charge recorded in 2020.
2021-12-31voluntary_separationcompleted2020-09United StatesCertain U.S. employeesUSD 43 (millions)other
f5-10k / GLM-5.3-flash-HTML
Program announced September 2020 for certain U.S. employees; most transitions completed by December 31, 2020, with a small number continuing into Q1 2021 (fiscal 2021). One-time severance charge recorded in Q4 2020. No employee count disclosed.
2021-12-31voluntary_separationcompleted2020-092021-03-31United StatesUSD 43 (millions)Note 14. Benefit Plans
f5-10k / Qwen3.6-27B-Q8_0
Announced Sept 2020. Most transitions completed by Dec 31, 2020, with a small number continuing into Q1 2021. One-time severance charge of $43 million recorded in Q4 2020.
2020-12-31voluntary_separationcompleted2020-092020-12-31United StatesCertain U.S. employees (Aflac U.S. / Parent Company)USD 43 (millions)other
f5-10k / GLM-5.3-flash-HTML
One-time severance charge recorded in Q4 2020; most transitions completed by December 31, 2020, with a small number continuing into Q1 2021. Package included twelve months of salary, 2020 targeted bonus payout, and one year of COBRA or retiree medical where eligible. Number of participating employees not disclosed.
2020-12-31acquisition_additioncompleted2020-11United StatesAflac U.S. (via Aflac and Aflac New York)USD 140 (millions)other
f5-10k / GLM-5.3-flash-HTML
Acquisition of Zurich North America's U.S. Corporate Life and Pensions business (group life, disability and absence management products) completed November 2020; associated value is total purchase consideration, not a severance/restructuring charge. Acquired employee headcount not disclosed. Company also agreed to reinsure in-force group life and disability policies on an indemnity basis.
2020-12-31voluntary_separationin_progress2020-092021-03-31United StatesAflac U.S. / certain U.S. employeesUSD 43 (millions)MD&A
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Package included twelve months of salary, targeted 2020 bonus and one year of COBRA/retiree medical. Most transitions completed by 2020-12-31 with a small number continuing into Q1 2021; charge recorded in Q4 2020. Number of participating employees not disclosed.
2020-12-31acquisition_additioncompleted2020-112020-11United StatesAflac U.S.USD 140 (millions)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Total consideration of $140 million; acquired group life, disability and absence management business plus supporting assets and platform. Headcount transferred not disclosed.
2020-12-31voluntary_separationcompleted2020-09-012020-12-31United StatesCorporate and OtherUSD 43 (millions)Item 1. Business - Human Capital
f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML
Voluntary separation program for certain U.S. employees announced in September 2020. Most transitions completed by December 31, 2020.
2020-12-31voluntary_separationcompleted2020-092020-12-31United StatesCorporateUSD 43 (millions)MD&A
f5-10k / Qwen3.6-27B-Q8_0
Voluntary separation program for certain U.S. employees. Most transitions completed by Dec 31, 2020, with a small number continuing into Q1 2021. Employee count not disclosed.
2020-09-30voluntary_separationannounced2020-09-152020-12-31United StatesAflac U.S. / Parent CompanyUSD 45 (millions)subsequent_events
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Volunteer period ran 2020-09-15 to 2020-10-01; participants notified in October 2020. Package includes 12 months salary, targeted 2020 bonus, and one year of COBRA/retiree medical. Number of employees affected not disclosed.
2020-09-30voluntary_separationannounced2020-09-302020-12-31United StatesCorporate and OtherUSD 45 (millions)subsequent_events
f5-10q / Qwen3.6-27B-Q8_0
Voluntary separation program for certain U.S. employees announced in September 2020. Volunteer period opened Sept 15 and closed Oct 1. Company expects a one-time severance charge of approx $45 million in Q4 2020. Transitions expected to be completed by Dec 31, 2020.
2019-12-31acquisition_additioncompleted2019-11United StatesAflac U.S. — dental and vision platform (Tampa, Florida)USD 75 (millions)business_combinations_footnote
f5-10k / GLM-5.3-flash-HTML
Acquired Argus Holdings, LLC and Argus Dental & Vision; headcount added through the acquisition not disclosed. Plus contingent consideration of up to $21 million over three years tied to performance targets.
2019-12-31acquisition_additioncompleted2019-11-30United StatesAflac U.S.USD 75 (millions)Item_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML
November 2019 acquisition of Argus Holdings, LLC and Argus Dental & Vision, Inc.; $75 million paid at closing plus up to $21 million contingent consideration over three years. No headcount added through the acquisition is disclosed.
2014-12-31restructuringcompleted2014-10-01United StatesAflac U.S. sales organizationItem_1_Business
f5-10k / GLM-5.3-flash-HTML
Sales-hierarchy reorganization begun in Q3 2014: commission-based state sales coordinator positions were eliminated and replaced by salaried market director roles effective October 1, 2014. Compensation-model change; no affected headcount or charge disclosed.
2014-12-31othercompleted2014-10-012014-12-31United StatesAflac U.S. sales organizationItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Eliminated the commission-based state sales coordinator role and created salaried market director positions effective October 1, 2014; no affected-employee count or charge disclosed. Implemented alongside pay-for-performance changes to district sales coordinator compensation in Q3-Q4 2014.
2009-12-31acquisition_additioncompleted2009-10-012009-10-01United StatesAflac U.S.USD 100 (millions)business_combinations_footnote
f5-10k / GLM-5.3-flash-HTML
Parent Company acquired Continental American Insurance Group (CAIG), including subsidiary CAIC, closing in Q4 2009 with segment inclusion effective October 1, 2009. Purchase consideration was $100 million, funded with internal capital; $97 million of net assets recognized at fair value. Number of employees added through the acquisition was not disclosed.
2009-12-31acquisition_additioncompletedUnited StatesAflac U.S.USD 100 (millions)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Closed in Q4 2009; $100 million purchase of Continental American Insurance Group, Inc. (CAIG), including subsidiary CAIC, recognized $97 million of net assets at fair value. CAIC included in the Aflac U.S. segment effective 2009-10-01. No headcount associated with the acquisition is disclosed.
2009-12-31acquisition_additioncompleted2009-12-312009-12-31United StatesAflac U.S.USD 100 (millions)Item 1. Business
f5-10k / Qwen3.6-27B-Q8_0
Parent Company purchased Continental American Insurance Group, Inc. (CAIG) in Q4 2009 for $100 million. Specific headcount added not disclosed.
2009-09-30acquisition_additioncompleted2009-07-012009-10-01United StatesAflac U.S.USD 100 (millions)subsequent_events
f5-10q / Qwen3.6-27B-Q8_0
Acquisition of Continental American Insurance Group, Inc. (CAIC) for $100 million. Closed in October 2009. Headcount not disclosed.
2009-06-30acquisition_additionannounced2009-07-292009-12-31United States (Columbia, South Carolina)Aflac U.S. — voluntary group insurancesubsequent_events
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Definitive agreement to purchase Continental American Insurance Group, Inc. (including Continental American Insurance Company) for $100 million, funded with internal capital; expected to close in Q4 2009. No headcount disclosed.
2005-09-30otherin_progressJapanAflac Japan distributionMD&A
f5-10q / GLM-5.3-flash-fp4-HTML
Agency recruitment program: nearly 900 agencies recruited in Q3, bringing cumulative 2005 recruitment to more than 3,100 agencies as of September 30, 2005; 2005 goal is 4,400 agencies. Expansion, not a reduction.
2005-09-30otherin_progressUnited StatesAflac U.S. operationsMD&A
f5-10q / GLM-5.3-flash-fp4-HTML
90-day premium-payment grace period granted in hurricane-affected areas; state-mandated grace periods extend into 2006. Increase in lapsed policies expected once grace periods end; no persistency impact in Q3. No workforce reduction disclosed.
2004-12-31othercompletedUnited StatesAflac U.S. — sales managementMD&A
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Management reorganization described as the primary cause of below-target 2004 U.S. sales growth; no employee counts, separation terms, or charges disclosed. Changes were continuing to affect associate recruiting, productivity and sales during 2004.
1998-12-31acquisition_additioncompleted1998JapanAFLAC Japan — policyholder services and direct marketingUSD 8 (millions)business_combinations_footnote
f5-10k / GLM-5.3-flash-HTML
Small Japanese insurance agency purchased in 1998; $8 million cash consideration per parent-only cash flow statement (Schedule II). Acquired headcount not disclosed.
1998-12-31divestiture_reductioncompleted1998-12-31TaiwanAll other operations — insuranceItem_1_Business
f5-10k / GLM-5.3-flash-HTML
Sale of the Taiwan insurance operation closed December 31, 1998, producing a nominal gain. Employees affected not disclosed. 1997 Canadian subsidiary sale excluded as prior fiscal year.
1998-12-31acquisition_additioncompleted1998-12-31JapanInsurance AgencyItem_1_Business
f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML
Company purchased a small Japanese insurance agency in 1998. Headcount not specified.
1998-12-31divestiture_reductioncompleted1998-12-31TaiwanInsuranceItem_1_Business
f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML
Sold insurance operation in Taiwan on December 31, 1998. Headcount not specified.
1997-12-31divestiture_reductioncompleted1997-04-15United StatesBroadcast operations (network-affiliated television stations)Item_1_Business
f5-10k / GLM-5.3-flash-HTML
Completed disposal of seven-station broadcast business; remaining six stations closed April 15, 1997 with a 1997 pretax gain of $267.2 million (seventh station closed December 31, 1996). Number of employees affected was not disclosed.
1997-12-31divestiture_reductioncompleted1997-03-12CanadaInsurance (Canadian subsidiary)Item_1_Business
f5-10k / GLM-5.3-flash-HTML
Canadian insurance subsidiary sold at a nominal gain; employees affected not disclosed. Filer also recognized 1997 expense charges for estimated termination costs related to other operations.
1997-12-31divestiture_reductioncompleted1997-04-15United StatesBroadcast DivisionItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Sale of seven network-affiliated television stations completed in 1997; six stations closed April 15, 1997. No employee headcount impact disclosed.
1997-12-31divestiture_reductioncompleted1997-03-12CanadaInsuranceItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Canadian insurance subsidiary sold March 12, 1997 at a nominal gain; no employee headcount impact disclosed.
1997-12-31divestiture_reductioncompleted1997-12-31United StatesBroadcast DivisionItem_1_Business
f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML
Company completed sale of broadcast business (seven TV stations) in 1997. No specific employee count disclosed for this divestiture.
1997-12-31divestiture_reductioncompleted1997-03-011997-03-12CanadaInsuranceItem_1_Business
f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML
Sold minor Canadian insurance subsidiary in March 1997. No specific employee count disclosed.
1997-12-31restructuringcompleted1997-12-31OtherOther OperationsItem_1_Business
f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML
Additional expense charges recognized in 1997 for estimated termination costs related to other operations (including Taiwan). No specific employee count disclosed.
1996-12-31divestiture_reductionin_progress19961997United StatesBroadcast Division (seven network-affiliated television stations)Item_1_Business
f5-10k / GLM-5.3-flash-HTML
Definitive agreements signed during 1996 to sell the entire broadcast division. Sale of the WAFB-TV station closed December 31, 1996; the remaining six stations were expected to close in the first half of 1997, subject to FCC approval. The division employed 477 full-time and 87 part-time employees at December 31, 1996; no combined division headcount was stated.
1996-12-31divestiture_reductioncompleted19961997-03-12CanadaMinor Canadian insurance subsidiary (Other operations)Item_1_Business
f5-10k / GLM-5.3-flash-HTML
Sale process disclosed as underway as of December 31, 1996; the transaction closed March 12, 1997, after fiscal year-end but before the filing date. Affected employee count was not disclosed.
1996-12-31divestiture_reductionin_progress1996-12-311997-06-30United StatesBroadcast Division (seven network-affiliated television stations)Item_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Definitive agreements entered during 1996 for sale of all seven TV stations; total pretax gain estimated at $325M. One station (WAFB-TV) closed 1996-12-31; remaining six expected to close in first half of 1997. Broadcast Division employed 477 full-time and 87 part-time at year-end; employee count affected by sale not separately stated.
1996-12-31divestiture_reductioncompleted1997-03-121997-03-12CanadaCanadian insurance subsidiaryItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML
Subsequent event: minor Canadian insurance subsidiary sold on 1997-03-12, after fiscal year-end but before filing date. Headcount affected not disclosed.
1996-12-31divestiture_reductioncompleted1996-12-311996-12-31United StatesBroadcastItem_1_Business
f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML
Sale of WAFB-TV closed Dec 31, 1996. Remaining 6 stations expected to close in H1 1997. Employee count for WAFB not explicitly disclosed, though total Broadcast division had 564 employees at year-end.
1996-12-31divestiture_reductioncompleted1997-03-121997-03-12CanadaOther InsuranceItem_1_Business
f5-10k / Qwen3.6-27B-NVFP4-MTP-HTML
Sold minor Canadian insurance subsidiary on March 12, 1997. Employee count not disclosed.
1996-09-30divestiture_reductionin_progress1996-08-131996-12-31United StatesBroadcast Division (seven network-affiliated television stations)other
f5-10q / MiMo-V2.6-Flash-fp8-HTML
Sales agreements entered August 1996; closing subject to FCC approval, expected late 1996 or early 1997. No employee counts or workforce impact disclosed. Also referenced in Part II Item 6 (Form 8-K dated 1996-08-13).